Facebook Linkedin Tumblr Twitter
Sign in
  • My Account
  • orders
Sign in
Welcome!Log into your account
Forgot your password?
Password recovery
Recover your password
Search
  • Sign in / Join
Facebook Linkedin Tumblr Twitter
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
Market Exclusive #1 Financial News & Analysis Market Exclusive
Market Exclusive #1 Financial News & Analysis
  • My Account
  • orders
Home Biotech Stocks

Biotech Stocks

Random
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random

Intra-Cellular Therapies, Inc. (NASDAQ:ITCI): Don’t Give Up On This One Yet

- May 2, 2017
BMW And International Business Machines Corp

International Business Machines Corp. (NYSE:IBM), Illumina, Inc. (NASDAQ:ILMN) To Partner With Munich Leukemia Laboratory

Medtronic PLC (NYSE:MDT) Seeking FDA Nod For Artificial Pancreas

Synergy Sets up for a Multi-billion Dollar NDA Submission

How Novartis AG (ADR) (NYSE:NVS) Uses Proceeds From Asset Sales Would Determine Its Future

Sanofi SA (NYSE:SNY) Suffers Setback Following Delay By FDA

- August 22, 2016 0
AbbVie Inc

Phase 2b Trial Demonstrates Positive Results For AbbVie Inc (NYSE:ABBV) Elagolix

- April 10, 2017 0

Allergan plc Ordinary Shares (NYSE:AGN) Incorporates Novartis AG (ADR) (NYSE:NVS) In...

Andy Parker - April 21, 2017 0

Biotech Movers: Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE) and PTC Therapeutics, Inc. (NASDAQ:PTCT)

- September 29, 2017 0
immy3

Clearing Up The confusion: Here’s What Imprimis Is Really Doing

Jennifer Aldershot - October 26, 2015 0
biotech

Biotech Movers: Puma Biotechnology Inc (NASDAQ:PBYI) and Regeneron Pharmaceuticals, Inc. (NASDAQ:...

- May 23, 2017 0
novo

Novo Nordisk A/S (ADR) (NYSE:NVO) Reaches Settlement Over Illegal ‘White Coat’...

- May 1, 2017 0
bacteria

Biotech Movers And Shakers: Synthetic Biologics, Inc. (NYSEMKT:SYN) and Conatus Pharmaceuticals...

- May 12, 2017 0
Walgreens Boots Alliance Inc

Generic Drug Prices Expected To Keep Falling As Walgreens Boots Alliance...

- August 4, 2017 0

Branded Products, Acquisitions To Be Allergan (NYSE:AGN) Focus

Andy Parker - June 27, 2017 0
123...146Page 1 of 146

Latest Articles

  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

August 2, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

July 13, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

July 6, 2026

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016
biotechnology

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

POPULAR CATEGORY

  • SEC Filings97015
  • Analyst Ratings21747
  • Insider Trading7769
  • Earnings4727
  • LSE4165
  • dividend announcements2433
  • Tech News1583
  • Stocks1511
  • Stock Market News1478
Market Exclusive #1 Financial News & Analysis
ABOUT US
Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.
Contact us: [email protected]
FOLLOW US
Facebook Linkedin Tumblr Twitter
  • SEC Filings
  • Stocks
  • Stock Market News
  • Tech News
  • Biotech Stocks
  • Featured
  • Small Caps
  • gold
  • Other News
  • Oil
  • Become a Contributor!
  • Advertise On Market Exclusive
  • Contact Us
© Market Exclusive 2019